Your browser doesn't support javascript.
loading
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies.
Ten-Blanco, Marc; Flores, África; Cristino, Luigia; Pereda-Pérez, Inmaculada; Berrendero, Fernando.
Affiliation
  • Ten-Blanco M; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, 28223 Pozuelo de Alarcón, Madrid, Spain.
  • Flores Á; Pharmacology Unit, Department of Pathology and Experimental Therapeutics, Neurosciences Institute, University of Barcelona and Bellvitge University Hospital-IDIBELL, 08908 L'Hospitalet de Llobregat, Barcelona, Spain.
  • Cristino L; Endocannabinoid Research Group, Institute of Biomolecular Chemistry (ICB), National Research Council (CNR), Pozzuoli, Italy.
  • Pereda-Pérez I; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, 28223 Pozuelo de Alarcón, Madrid, Spain.
  • Berrendero F; Faculty of Experimental Sciences, Universidad Francisco de Vitoria, 28223 Pozuelo de Alarcón, Madrid, Spain. Electronic address: fernando.berrendero@ufv.es.
Front Neuroendocrinol ; 69: 101066, 2023 04.
Article in En | MEDLINE | ID: mdl-37015302
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuropeptides / Neurodegenerative Diseases Limits: Animals / Humans Language: En Journal: Front Neuroendocrinol Year: 2023 Document type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neuropeptides / Neurodegenerative Diseases Limits: Animals / Humans Language: En Journal: Front Neuroendocrinol Year: 2023 Document type: Article Affiliation country: Spain